CompaniesAC Diagnostics

AC Diagnostics

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (2)
View all

Total Trials

2

As Lead Sponsor

0

As Collaborator

2

Total Enrollment

300

By Phase

PHASE2: 2

By Status

RECRUITING: 2
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2022
2023
2024
2025
2026
2027
2028
Today
NCT04838301
NCT05664477
Hover over trial bars to see details

Recent Trials

NCT05664477Collaborator
PhytoSERM to Prevent Menopause Associated Decline in Brain Metabolism and Cognition
PHASE2Recruiting
100 participants
Started: Jan 10, 2024 · Completed: Jan 31, 2027
NCT04838301Collaborator
Allopregnanolone Regenerative Therapeutic for Mild Alzheimer's Disease
PHASE2Recruiting
200 participants
Started: Aug 15, 2023 · Completed: Apr 30, 2026